Pasar al contenido principal

Investigación y educación

Enviado por remote_content el

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses. Lancet.

Investigación y Educación

WHO Solidarity Trial Consortium. 02/05/2022

Background
The Solidarity trial among COVID-19 inpatients has previously reported interim mortality analyses for four repurposed antiviral drugs. Lopinavir, hydroxychloroquine, and interferon (IFN)-β1a were discontinued for futility but randomisation to remdesivir continued. Here, we report the final results of Solidarity and meta-analyses of mortality in all relevant trials to date.

Read full article

Artículos que te pueden interesar

Enfermedades infecciosas

Knowledge, attitudes, and behavior regarding antibiotics, antibiotic use, and antibiotic resistance in students and health care professionals of the district of Barranquilla (Colombia): A cross-sectional survey. Heliyon.

Noviembre 1, 2022

Leer más

Enfermedades infecciosas

Risk Factors for Mortality in Colombian Patients with Candidemia. J Fungi (Basel).

Mayo 31, 2021

Leer más

Enfermedades infecciosas

A simplified alternative diagnostic algorithm for SARS-CoV-2 suspected symptomatic patients and confirmed close contacts (asymptomatic): A consensus of Latin American experts. Int J Infect Dis.

Mayo 20, 2021

Leer más